beta-Adrenergic receptor blockers are one of a number of therapeutic agents promoted as having beneficial effects in vasovagal syncope. In this issue of Clinical Science, Eldadah and co-workers have investigated the effect of the beta-adrenergic receptor blocker propranolol in preventing syncope in a double-blind cross-over trial in eight subjects with a diagnosis based on tilt table testing and elevated plasma adrenaline levels during syncope. Of these, seven did not respond and the authors therefore suggest that this drug has no role in the management of vasovagal syncope. Their laboratory-based study, however, raises a number of issues regarding terminology, choice of subjects, the value and role of investigations directed towards diagnosis and in understanding pathophysiological mechanisms, and the relevance of such trials to individual subjects with vasovagal syncope.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1042/CS20060174 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Tilt Induced Syncope in Patients with a History of Vasovagal Syncope or Near Syncope.
Heart Rhythm
January 2025
Centre for Cardiovascular Research and Nutrition, C2VN, INSERM, INRAE, AMU, Marseille, France; Laboratory of Biochemistry, AP-HM, Marseille, France.
Syncopal reactions in blood donors: Pathophysiology, clinical course, and features.
Asian J Transfus Sci
September 2022
Department of Physiology, Mahatma Gandhi Medical College, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India.
Vasovagal syncope (VVS) in donors is a transient loss of consciousness due to short-term global cerebral hypoperfusion, which has a rapid onset and has complete spontaneous recovery. VVS may be triggered by pain, fear, anxiety, or emotional upset and loss of blood perse. It is an exaggeration of an adaptive response meant to assist in reducing the amount of bleeding/loss of blood.
View Article and Find Full Text PDFNomogram Based on HRV for Predicting the Therapeutic Effects of Orthostatic Training in Children with Vasovagal Syncope.
Children (Basel)
November 2024
Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Background: This study intended to find out whether the parameters of heart rate variability (HRV) can predict the treatment efficacy of orthostatic training among pediatric cases of vasovagal syncope (VVS).
Methods: Patients with VVS who underwent orthostatic training were retrospectively enrolled. Lasso and logistic regression were used to sift through variables and build the model, which is visualized using a nomogram.
The evolving role of head up tilt test: New protocol and indications for optimizing the care of syncope patients.
Eur J Intern Med
January 2025
IRCCS Istituto Auxologico Italiano, Faint & Fall programme, Cardiology Unit and Department of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital, Milan, Italy.
Cardiac deceleration capacity and acceleration capacity have diagnostic value in patients with vasovagal syncope regardless of age.
Front Cardiovasc Med
December 2024
Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China.
Article Synopsis
- The study aimed to assess autonomic nervous function in patients with vasovagal syncope (VVS) by comparing deceleration capacity (DC) and acceleration capacity (AC) between VVS patients and healthy controls.
- Significant differences were found, with VVS patients showing higher DC and lower AC values, as well as increased heart rate variability.
- DC and AC were recognized as independent predictors for syncope, suggesting that these measures could serve as useful indicators for evaluating cardiac autonomic dysfunction in clinical settings.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!